{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:41:58Z","timestamp":1767789718462,"version":"3.49.0"},"reference-count":30,"publisher":"Stanford University Press","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 19 K05721"],"award-info":[{"award-number":["JP 19 K05721"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jmsacl.2025.04.001","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T01:21:39Z","timestamp":1746062499000},"page":"28-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Serum peptides as candidate biomarkers for relapsing polychondritis"],"prefix":"10.21627","volume":"37","author":[{"given":"Toshiyuki","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3093-8645","authenticated-orcid":false,"given":"Kouhei","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0571-0592","authenticated-orcid":false,"given":"Masahiko","family":"Fukasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teisuke","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1004-538X","authenticated-orcid":false,"given":"Atsuhiro","family":"Tsutiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Omoteyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1238-6612","authenticated-orcid":false,"given":"Mitsumi","family":"Arito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Takakuwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5635-345X","authenticated-orcid":false,"given":"Seido","family":"Ooka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Suematsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimito","family":"Kawahata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Yamano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6503-404X","authenticated-orcid":false,"given":"Manae S.","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4811","reference":[{"issue":"2","key":"10.1016\/j.jmsacl.2025.04.001_b0005","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.berh.2016.08.001","article-title":"Relapsing polychondritis: A 2016 update on clinical features, diagnostic tools, treatment and biological drug use","volume":"30","author":"Mathian","year":"2016","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.jmsacl.2025.04.001_b0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11926-015-0549-5","article-title":"Relapsing polychondritis: an update on pathogenesis, clinical features, diagnostic tools, and therapeutic perspectives","volume":"18","author":"Vitale","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"issue":"9","key":"10.1016\/j.jmsacl.2025.04.001_b0015","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/rheumatology\/kex406","article-title":"Relapsing polychondritis: a clinical review for rheumatologists","volume":"57","author":"Kingdon","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.jmsacl.2025.04.001_b0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00005792-197605000-00001","article-title":"Relapsing polychondritis: prospective study of 23 patients and a review of the literature","volume":"55","author":"McAdam","year":"1976","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jmsacl.2025.04.001_b0025","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1288\/00005537-197906000-00009","article-title":"Relapsing polychondritis\u2013report of ten cases","volume":"89","author":"Damiani","year":"1979","journal-title":"Laryngoscope"},{"issue":"8","key":"10.1016\/j.jmsacl.2025.04.001_b0030","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/ndt\/16.8.1705","article-title":"Late allograft loss due to recurrence of p-ANCA-associated systemic vasculitis in a patient with relapsing polychondritis","volume":"16","author":"Masterson","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jmsacl.2025.04.001_b0035","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-008717","article-title":"Occurrence of relapsing polychondritis with a rising cANCA titre in a cANCA-positive systemic and cerebral vasculitis patient","author":"Mattiassich","year":"2013","journal-title":"BMJ Case Rep."},{"issue":"5","key":"10.1016\/j.jmsacl.2025.04.001_b0040","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3899\/jrheum.101238","article-title":"Combination of hypertrophic pachymeningitis, PR3-ANCA-positive vasculitis, and relapsing polychondritis","volume":"38","author":"Ca\u00f1as","year":"2011","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/j.jmsacl.2025.04.001_b0045","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/ard.40.5.473","article-title":"Autoantibodies to cartilage and type II collagen in relapsing polychondritis and other rheumatic diseases","volume":"40","author":"Ebringer","year":"1981","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.jmsacl.2025.04.001_b0050","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/1529-0131(200110)44:10<2402::AID-ART405>3.0.CO;2-L","article-title":"The occurrence of autoantibodies to matrilin 1 reflects a tissue-specific response to cartilage of the respiratory tract in patients with relapsing polychondritis","volume":"44","author":"Hansson","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.jmsacl.2025.04.001_b0055","first-page":"553","article-title":"Serum cartilage oligomeric matrix protein (COMP) level is a marker of disease activity in relapsing polychondritis","volume":"28","author":"Kempta Lekpa","year":"2001","journal-title":"Clin. Exp. Rheumatol."},{"issue":"11","key":"10.1016\/j.jmsacl.2025.04.001_b0060","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1177\/000348940111001108","article-title":"Serum level of macrophage migration inhibitory factor as a useful parameter of clinical course in patients with Wegener's granulomatosis and relapsing polychondritis","volume":"110","author":"Ohwatari","year":"2001","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"issue":"1","key":"10.1016\/j.jmsacl.2025.04.001_b0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/14397595.2013.852854","article-title":"Serum level of soluble triggering receptor expressed on myeloid cells-1 as a biomarker of disease activity in relapsing polychondritis","volume":"24","author":"Sato","year":"2014","journal-title":"Mod. Rheumatol."},{"issue":"10","key":"10.1016\/j.jmsacl.2025.04.001_b0070","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1002\/art.11281","article-title":"Urinary type II collagen neoepitope as an outcome measure for relapsing polychondritis","volume":"48","author":"Kraus","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.jmsacl.2025.04.001_b0075","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","article-title":"The human plasma proteome: history, character, and diagnostic prospects","volume":"1","author":"Anderson","year":"2002","journal-title":"Mol. Cell Proteomics."},{"issue":"11","key":"10.1016\/j.jmsacl.2025.04.001_b0080","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1002\/art.30560","article-title":"AC13, a C-terminal fragment of apolipoprotein A-I, is a candidate biomarker for microscopic polyangiitis","volume":"63","author":"Takakuwa","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.jmsacl.2025.04.001_b0085","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/gps.4274","article-title":"Serum peptides as candidate biomarkers for dementia with lewy bodies","volume":"30","author":"Suzuki","year":"2015","journal-title":"Int. J. Geriatr. Psychiatry."},{"issue":"7","key":"10.1016\/j.jmsacl.2025.04.001_b0090","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/hepr.12018","article-title":"Serum peptides, represented by complement 3f des-arginine, are useful for prediction of the response to pegylated interferon-\u03b1 plus ribavirin in patients with chronic hepatitis C","volume":"43","author":"Noguchi","year":"2013","journal-title":"Hepatol. Res."},{"issue":"8","key":"10.1016\/j.jmsacl.2025.04.001_b0095","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/gps.4047","article-title":"Roles of serum fibrinogen \u03b1 chain-derived peptides in Alzheimer's disease","volume":"29","author":"Noguchi","year":"2014","journal-title":"Int. J. Geriatr. Psychiatry."},{"issue":"3","key":"10.1016\/j.jmsacl.2025.04.001_b0100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.jmsacl.2025.04.001_b0105","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.jmsacl.2025.04.001_b0110","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American college of rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.jmsacl.2025.04.001_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"Revised international chapel hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jmsacl.2025.04.001_b0120","doi-asserted-by":"crossref","unstructured":"P.M. Bossuyt, et al., STARD Group. 2015. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies, BMJ. 351:h5527 (2015) 10.1136\/bmj.h5527.","DOI":"10.1136\/bmj.h5527"},{"issue":"1","key":"10.1016\/j.jmsacl.2025.04.001_b0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jdermsci.2017.03.014","article-title":"Serum peptides as putative modulators of inflammation in psoriasis","volume":"87","author":"Matsuura","year":"2017","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jmsacl.2025.04.001_b0130","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/978-3-319-49674-0_13","article-title":"Fibrin formation, structure and properties","volume":"82","author":"Weisel","year":"2017","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.jmsacl.2025.04.001_b0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12014-016-9129-6","article-title":"Fibrinogen alpha C chain 5.9kDa fragment (FIC5.9), a biomarker forvarious pathological conditions, is produced inpost-blood collection byfibrinolysis andcoagulation factors","volume":"13","author":"Kikuchi","year":"2016","journal-title":"Clin. Proteom."},{"key":"10.1016\/j.jmsacl.2025.04.001_b0140","doi-asserted-by":"crossref","unstructured":"S. Homma, et al., Relapsing polychondritis. Pathological and immunological findings in an autopsy case, Acta. Pathol. Jpn. 34 (5) (1984) 1137-1146. 10.1111\/j.1440-1827.1984.tb07641.x.","DOI":"10.1111\/j.1440-1827.1984.tb07641.x"},{"key":"10.1016\/j.jmsacl.2025.04.001_b0145","first-page":"188","article-title":"Three case reports of relapsing polychondritis and their immunopathological analysis","volume":"27","author":"Miyagi","year":"1989","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"10.1016\/j.jmsacl.2025.04.001_b0150","series-title":"Serum Peptides as Candidate Biomarkers for Relapsing Polychondritis","author":"Sato","year":"2023"}],"container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X25000082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X25000082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:22:50Z","timestamp":1767770570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667145X25000082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":30,"alternative-id":["S2667145X25000082"],"URL":"https:\/\/doi.org\/10.1016\/j.jmsacl.2025.04.001","relation":{},"ISSN":["2667-145X"],"issn-type":[{"value":"2667-145X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum peptides as candidate biomarkers for relapsing polychondritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Mass Spectrometry and Advances in the Clinical Lab","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmsacl.2025.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 THE AUTHORS. Publishing services by ELSEVIER B.V. on behalf of MSACL.","name":"copyright","label":"Copyright"}]}}